Unidad de Investigación de Análisis y Síntesis de Evidencia, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México, México.
Unidad de Investigación en Epidemiología Clínica, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México, México.
Arch Med Res. 2022 Apr;53(3):252-262. doi: 10.1016/j.arcmed.2022.03.001. Epub 2022 Mar 14.
COVID-19 is an infectious disease of variable severity caused by a new coronavirus. Clinical presentation ranges from asymptomatic cases to severe illness. Most cases in newborns appear to be asymptomatic or mild.
To conduct a systematic review of the literature on published studies of COVID-19 in newborns with a positive RT-PCR test.
The PubMed and EMBASE databases were searched for infection data in newborns from 1 December 2019-21 May 2021. The mesh terms included "SARS-CoV-2", "COVID-19", "novel coronavirus", "newborns" and "neonates". The selection criteria were as follows: original studies reporting clinical, radiological, laboratory, and outcome data in newborns with a positive RT-PCR test for SARS-CoV-2. Two independent investigators reviewed the studies.
Seventy-two studies that involved 236 newborns were included. The main clinical manifestations were fever (43.2%), respiratory (46.6%), and gastrointestinal (35.2%) symptoms; 60.1% had mild/moderate disease. A total of 52.5% had a chest X-ray; 43.5% were normal, and 24.1% reported consolidation/infiltration images. The most frequent laboratory abnormalities were elevated C reactive protein and elevated procalcitonin and lymphopenia. Mortality was 1.7%.
Symptoms of SARS-CoV-2 infection were mild to moderate in most of the newborns. The prognosis was good, and mortality was mainly associated with other comorbidities.
COVID-19 是一种由新型冠状病毒引起的严重程度不同的传染病。临床表现从无症状病例到重症病例不等。大多数新生儿病例似乎无症状或轻症。
对已发表的关于 RT-PCR 检测呈阳性的 COVID-19 新生儿病例的文献进行系统综述。
检索了 2019 年 12 月 1 日至 2021 年 5 月 21 日期间在 PubMed 和 EMBASE 数据库中关于新生儿感染的数据。使用的主题词包括“SARS-CoV-2”、“COVID-19”、“新型冠状病毒”、“新生儿”和“新生儿”。选择标准如下:报告了 RT-PCR 检测 SARS-CoV-2 阳性的新生儿的临床、放射学、实验室和结局数据的原始研究。两名独立的调查人员对研究进行了审查。
共纳入了 72 项涉及 236 名新生儿的研究。主要临床表现为发热(43.2%)、呼吸道(46.6%)和胃肠道(35.2%)症状;60.1%为轻症/中度疾病。共有 52.5%的患儿行胸部 X 线检查;43.5%正常,24.1%有实变/浸润影。最常见的实验室异常为 C 反应蛋白和降钙素原升高及淋巴细胞减少。死亡率为 1.7%。
大多数新生儿的 SARS-CoV-2 感染症状为轻至中度。预后良好,死亡率主要与其他合并症有关。